The Era of Antibiotics and Modern Challenges
For centuries, infectious diseases have been one of the leading causes of mortality. The discovery of penicillin and the subsequent emergence of antibiotics became a breakthrough, making it possible to successfully treat previously fatal diseases and significantly increasing life expectancy [1, 7].
However, the triumph of antibiotics is overshadowed by the emergence of drug-resistant microorganisms. The widespread use of antibacterial drugs has led to the evolution of bacteria that have developed defense mechanisms, resulting in multidrug resistance (MDR) [1, 2]. This trend makes the treatment of serious bacterial infections increasingly complex and critical [2]. For example, conditions such as bacteremia caused by methicillin-resistant Staphylococcus aureus (MRSA), including infective endocarditis, have high mortality rates, and up to 50% of patients do not respond to standard vancomycin therapy, necessitating the search for alternative approaches [4]. Facing this global threat, scientists are actively searching for new, non-antibiotic strategies to combat infectious diseases [1]. Among the most promising alternatives are bacteriophages, or phages [1, 2].
What are Bacteriophages and How Do They Work?
Bacteriophages, often simply called phages, represent a unique class of viruses that have the ability to selectively infect and destroy bacteria [3]. Their name, literally meaning "bacteria eater," accurately reflects their function. These microscopic agents are among the most abundant biological entities on the planet and play a fundamental role in maintaining ecological balance, including within the human body, where they are major components of the gut virome [2].
A key feature of phages is their high specificity: each type of phage targets a specific species or strain of bacteria [3]. This distinguishes them from broad-spectrum antibiotics, which destroy both pathogenic and beneficial bacteria, disrupting the microbiome. Phages, on the other hand, are capable of attacking harmful microorganisms while leaving beneficial microflora intact, which is of utmost importance for maintaining the health of the gut, skin, and other biotopes [2, 3]. Mechanism of action: a phage attaches to a bacterial cell, injects genetic material, uses cellular machinery to make copies of itself, which leads to lysis (destruction) of the bacterium and the release of new phages [2].
Phage Therapy: Relevance in the Era of Resistance
Amidst the rising number of multidrug-resistant bacteria, phage therapy is gaining special relevance. Bacteriophages are natural antibacterial agents capable of effectively overcoming resistance against which traditional antibiotics are powerless [2]. Their ability to proliferate rapidly directly at the site of infection and their high specificity make them an extremely attractive alternative or valuable addition to existing therapeutic strategies [2].
Every year, treating serious bacterial infections becomes increasingly difficult due to the growing number of strains demonstrating high and multidrug resistance [2]. Phage therapy offers an innovative approach that can be especially useful in the following clinical scenarios:
- Infections caused by bacteria resistant to all available antibiotics.
- Cases where the patient exhibits intolerance to antibiotics or has severe contraindications to their use.
- The necessity of preserving the balance of normal microflora, for example, during prolonged treatment courses or in immunocompromised patients where microbiome disruption can lead to secondary infections.
Broad Spectrum of Application: From Gut to Skin
The potential of phage therapy is broad and actively researched in various fields. Special attention is paid to the role of phages in maintaining gut health, whose microbiota plays a fundamental role in regulating the pathogenesis of many diseases [2]. Bacteriophages, as major members of the gut virome, exert selective pressure on bacterial communities living in the intestinal tract, thereby influencing homeostasis and helping maintain a healthy microflora balance [2].
Dermatology represents another promising area for the application of phage therapy. Many common skin conditions, such as acne, psoriasis, and atopic dermatitis, are characterized not only by an imbalance of bacterial microflora (dysbiosis) but also by a relative decrease in phage numbers alongside the overgrowth of corresponding bacteria [3]. In this context, replacement phage therapy aimed at restoring normal phage composition and targeted control of pathogenic bacteria demonstrates promising results in treating these dermatological conditions [3]. However, despite encouraging data, current clinical trials are often limited by small sample sizes and a lack of control groups, necessitating larger-scale studies [3].
Advantages and Future Prospects of Phage Therapy
Bacteriophages possess several unique advantages that make them extremely attractive as therapeutic agents in the face of growing antibiotic resistance:
- High specificity: Phages selectively target only specific bacteria, minimizing negative impact on the body's beneficial microflora [2, 3]. This helps avoid many side effects associated with broad-spectrum antibiotics.
- Efficacy against resistant strains: They are capable of destroying bacteria that have developed resistance to multiple antibiotics, offering a solution for "superbugs" [2].
- Self-replication at the infection site: Phages replicate only in the presence of host bacteria, which can provide a prolonged and localized therapeutic effect, reducing the need for repeated doses [2].
- Low toxicity and minimal side effects: Because phages do not infect human cells, they are generally well tolerated and associated with a minimal risk of serious adverse reactions.
- Rapid action: Through the lysis mechanism, phages can rapidly destroy bacterial cells.
Despite significant progress and promising results, phage therapy is still in the stage of active development and requires further in-depth research and standardization. To fully confirm its efficacy and safety, larger, well-designed clinical trials with adequate control groups are necessary [3]. Nevertheless, bacteriophages represent a powerful, natural, and highly specific tool that has every chance of becoming a cornerstone in the arsenal against infectious diseases in the post-antibiotic era, offering real hope for the effective treatment of even the most complex and resistant infections.
Sources
- 1. Joice, S. (2014). Treatment of infectious diseases: beyond antibiotics. Microbiological research, 24661689.
- 2. Kim, Y., & Kim, S. (2022). Current status of phage therapy against infectious diseases and potential applications beyond infectious diseases. International journal of clinical practice, 36263241.
- 3. Kim, B. S., et al. (2023). Bacteriophages and microbiome in dermatology: the role of the phagemand potential therapeutic strategy. International journal of molecular sciences, 36769020.
- 4. Tong, S. Y. C., & Liew, Y. X. (2016). When sepsis persists: a review of rescue therapy for MRSA bacteremia. The Journal of antimicrobial chemotherapy, 26565015.
- 7. Singh, A., & Singh, R. (2020). Antibiotics: from origin to future: Part 1. Indian journal of pediatrics, 31713213.
The information presented in this article is for informational purposes only and should not be used for self-diagnosis or self-treatment. Always consult a qualified healthcare professional for an accurate diagnosis and appropriate treatment prescription.